How many days does a box of Quizartinib last?
Quizartinib (Quizartinib) is an oral small molecule targeted drug, usually taken by patients in tablet form, for the treatment of acute myeloid leukemia (AML) associated with FLT3-ITD mutations. Its common specifications are 17.7mg (28 tablets/box) and 26.5mg (56 tablets/box). These two specifications are mainly designed to meet different stages and dosage needs. According to the description of overseas marketed drugs, the standard recommended dose of Quizartinib is mostly once a day, and the specific dose is adjusted by the doctor based on the patient's tolerance and efficacy.

Drug dosage may be adjusted due to individual differences, liver function status, or interactions with other drugs. For example, during certain maintenance treatment phases or when tolerance decreases, doctors may temporarily adjust the dose and extend or shorten the treatment course. The regularity of taking Quizartinib is very important. Patients need to take it orally at a fixed time every day, preferably with food to reduce gastrointestinal discomfort. The tablet should be swallowed whole, without crushing or chewing, to ensure stable absorption of the drug in the body. If the patient forgets to take the medication, he should not take additional doses and should continue with the next cycle to avoid adverse reactions caused by excessive dosage.
Since Quizartinib has not yet been launched in mainland China, if domestic patients currently need to use it, they usually need to obtain it through overseas drug purchase channels. Therefore, before purchasing, you should ensure that the source of medicines is legitimate to avoid the risk of fake or expired medicines. After the drug is approved to enter the domestic market in the future, patients will be able to use it in a standardized manner in the hospital prescription system and enjoy more complete medication guidance and pharmaceutical management.
Generally speaking, how many days you can take a box of Quizartinib mainly depends on the packaging specifications and the treatment plan prescribed by the doctor. Patients should strictly follow the doctor's advice and not change the dosage arbitrarily to ensure efficacy and safety.
Reference materials:https://go.drugbank.com/drugs/DB12874
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)